[Experiences with trimethoprim-sulfamethoxazole in the chemotherapy of bacterial infections].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D001437:Bacteriuria / Q000175:diagnosis; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D002648:Child; D002908:Chronic Disease; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008439:Maxillary Diseases / Q000188:drug therapy; D008875:Middle Aged; D010292:Paresthesia / Q000139:chemically induced; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D012852:Sinusitis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Erfahrungen mit Trimethoprim-Sulfamethoxazol in der Chermotherapie bakterieller Infektionen.